You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Prevention of cochlear implant electrode damage

Eshraghi, Adrien A

Current Opinion in Otolaryngology & Head & Neck Surgery:
doi: 10.1097/01.moo.0000244189.74431.df
Hearing science
Abstract

Purpose of review: As the current trend in cochlear implantation is to prescribe cochlear implants for patients with residual hearing and to use electroacoustic stimulation, cochlear implant damage must be prevented. This article summarizes current research endeavors to prevent electrode insertion trauma and resulting hearing loss.

Recent findings: Alteration in surgical technique is necessary with each new electrode design. Nontraumatic surgical technique also requires minimizing acoustic trauma due to drilling the cochleostomy, mechanical damage from electrode insertion, potential infection, and fibrosis of the cochlea. The pattern of hearing loss following electrode insertion trauma is an immediate loss that results from direct trauma to the macroscopic elements of the cochlea and a delayed loss that may reflect the activation of inflammatory and cell death pathways. Therapies under investigation include glucocorticoids, inhibitors of cell death pathways, and hypothermia.

Summary: Electrode insertion trauma-induced hearing loss involves multiple mechanisms ranging from mechanical insertion trauma to activation of inflammatory and cell death pathways. The macroscopic mechanical damage to the cochlea may be prevented by improvement of electrode design and surgical technique. The molecular damage needs further studies to assess the efficacy of novel therapeutic strategies in preserving functional residual hearing.

Author Information

University of Miami Ear Institute, Department of Otolaryngology, University of Miami, Miller School of Medicine, Miami, Florida, USA

Correspondence to Adrien A. Eshraghi, MD, Associate Professor of Otolaryngology, 1666 NW 10th Ave # 306, Miami, FL 33136, USA Tel: +1 305 585 7126; fax: +1 305 326 7610; e-mail: Aeshraghi@med.miami.edu

© 2006 Lippincott Williams & Wilkins, Inc.